Pan H C, Chung W Y, Guo W Y, Chang Y C, Shiau C Y, Wang L W, Liu R S, Ngo F Q, Lee L S
Division of Functional Neurosurgery, Veterans General Hospital-Taipei, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 1998 Jul;61(7):397-407.
Gamma knife radiosurgery is a safe and effective alternative to microsurgery in the management of selected intracranial lesions. In our initial three-year experience with gamma knife radiosurgery, 431 patients were treated using this method. This report presents the treatment results for three different types of brain tumors: benign meningiomas, malignant metastases and gliomas.
A retrospective study was performed to analyze a consecutive series of 71 meningiomas, 31 metastatic tumors and 21 gliomas treated by gamma knife radiosurgery between March 1993 and May 1996. The treatment results were investigated using regular magnetic resonance examinations and tumor volume measurement at six-month intervals to observe sequential changes of the tumors. Patients with meningiomas were further divided into three groups according to the peripheral radiation doses: high-dose (20-17 Gy, n = 18), medium-dose (16-15 Gy, n = 33) and low-dose (14-12 Gy, n = 20). The Generalized Estimation Equation was applied to compare treatment results in these three groups with different doses and tumor volumes.
Volume measurements of the 71 meningiomas showed that 76% decreased in size, 16% stabilized and 8% increased in size. The volumes increased most frequently in the early stage (6-12 months) after treatment and subsequently regressed after the twelfth month. The tumor control rate for meningiomas in our three-year follow-up was over 90%. For meningiomas, the statistical analysis showed that both the radiation dose and tumor volume were significantly related to the development of adverse radiation effects (p < 0.05). In metastatic tumors, rapid tumor regression after radiosurgery was found in 87% of the patients. In gliomas, radiosurgery effectively inhibited tumor growth in selected patients with small, circumscribed, less infiltrative tumors. Ependymomas and low-grade astrocytomas had more favorable outcomes than other gliomas.
Gamma knife radiosurgery is effective for controlling tumor growth in benign meningiomas for up to three years after surgery. In selected cases of malignant metastasis and gliomas, most patients appeared to benefit from the treatment with symptomatic improvement and prolonged survival. Treatment strategy and dose selection in radiosurgery should be adjusted to optimize tumor control and avoid adverse radiation effects.
在特定颅内病变的治疗中,伽玛刀放射外科手术是一种安全有效的显微外科替代方法。在我们最初三年的伽玛刀放射外科手术经验中,431例患者接受了该方法治疗。本报告介绍了三种不同类型脑肿瘤的治疗结果:良性脑膜瘤、恶性转移瘤和胶质瘤。
进行一项回顾性研究,分析1993年3月至1996年5月期间连续接受伽玛刀放射外科手术治疗的71例脑膜瘤、31例转移瘤和21例胶质瘤。通过定期磁共振检查和每六个月测量肿瘤体积来观察肿瘤的连续变化,以此研究治疗结果。脑膜瘤患者根据外周辐射剂量进一步分为三组:高剂量组(20 - 17 Gy,n = 18)、中剂量组(16 - 15 Gy,n = 33)和低剂量组(14 - 12 Gy,n = 20)。应用广义估计方程比较这三组不同剂量和肿瘤体积的治疗结果。
71例脑膜瘤的体积测量显示,76%体积缩小,16%稳定,8%体积增大。体积增加最常发生在治疗后的早期(6 - 12个月),随后在第12个月后缩小。在我们三年的随访中,脑膜瘤的肿瘤控制率超过90%。对于脑膜瘤,统计分析表明辐射剂量和肿瘤体积均与不良放射效应的发生显著相关(p < 0.05)。在转移瘤中,87%的患者在放射外科手术后肿瘤迅速缩小。在胶质瘤中,放射外科手术有效地抑制了部分体积小、边界清晰、浸润性较小的肿瘤患者的肿瘤生长。室管膜瘤和低级别星形细胞瘤的治疗效果优于其他胶质瘤。
伽玛刀放射外科手术在术后长达三年的时间里对控制良性脑膜瘤的肿瘤生长有效。在特定的恶性转移瘤和胶质瘤病例中,大多数患者似乎从治疗中获益,症状得到改善,生存期延长。放射外科手术的治疗策略和剂量选择应进行调整,以优化肿瘤控制并避免不良放射效应。